Female Sexual Dysfunction and Satisfaction.
Conditions
Interventions
Intervention 1: Taking 100 mg sildenafil tablets 1 hour before each vaginal intercourse for 3 months. Intervention 2: Taking sildenafil tablets 1 hour before sexual intercourse for 3 months.
Treatment - Drugs
Placebo
Taking 100 mg sildenafil tablets 1 hour before each vaginal intercourse for 3 months
Taking sildenafil tablets 1 hour before sexual intercourse for 3 months
Sponsors
Vice chancellor for research, Tarbiyat Modares Univercity
Eligibility
Sex/Gender
Female
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 45-65 years old in post menopause and 25-45 years old in premenstrual women; Being sexually active; at least 12 month amenorah in post menopause women; no surgical menopause; no hormone replacement therapy; BMI= 19.8-30; no high BP; no drug use;no smoking; no alcohol; no liver; heart; thyroid disease or diabetic; no chronic disease; no cancer or precancerous disease; no vaginal bleeding;no endometrial hyperplasia or polyp; no pelvic radiation.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of female sexual satisfaction and sexual function. Timepoint: Three months after the intervention. Method of measurement: Complete Sexual Function Questionnaire (FSFI) and Sexual Satisfaction (ISS) before and after intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Effect on Endometrial Thickening and Interaepitelial Maturation Index in Menopause Women. Timepoint: Three Months after the Intervention. Method of measurement: Vaginal Sonography and Pap smear. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzar Mashhoori Vayghan
Tarbiat Modares Univercity
Outcome results
None listed